Inhibrx Biosciences Inc.
INBX | NASDAQ
$111.42
-$0.62 (-0.55%)
Sep 22, 2026, 12:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 124.22M | 152.6M | 277.92M | 273.87M | 131.3M | 128.66M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.38M | 6.83M | 3.16M | 3.16M | 1.85M | 245K |
Receivables | 177K | 420K | 778K | 257K | 878K | 615K |
Inventory | n/a | n/a | n/a | n/a | -878K | -129.28M |
Other Current Assets | 238K | 816K | 728K | 181K | 7.81M | 132.17M |
Total Current Assets | 132.83M | 160.4M | 295.36M | 280.49M | 139.11M | 132.17M |
Property-Plant & Equipment | 9.27M | 13.54M | 9.37M | 7.22M | 9.49M | 11.32M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.65M | 20.37M | 12.54M | 10.38M | 11.34M | 11.57M |
Total Assets | 146.48M | 180.77M | 307.89M | 290.88M | 150.45M | 143.74M |
Account Payables | 5.94M | 9.25M | 10.95M | 8.33M | 9.13M | 13.46M |
Deferred Revenue | n/a | n/a | n/a | 166K | 2.03M | 3.08M |
Short-Term Debt | 2.33M | 1.6M | n/a | 1.86M | 1.67M | 1.5M |
Other Current Liabilities | 18.08M | 7.73M | 6.51M | 13.85M | 9.62M | 13.36M |
Total Current Liabilities | 33.8M | 40.73M | 56.31M | 27.58M | 22.45M | 31.4M |
Long-Term Debt | 100.56M | n/a | 206.97M | 202.07M | 70.47M | 35.95M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 5.03M | 180K |
Total Long-Term Liabilities | 104.69M | 6.45M | 208.08M | 205.24M | 75.61M | 36.87M |
Total Liabilities | 138.49M | 47.18M | 264.39M | 232.82M | 98.07M | 68.27M |
Total Debt | 107.01M | 8.05M | 210.14M | 207.1M | 72.14M | 37.45M |
Book Value | 7.99M | 133.58M | 43.5M | 58.06M | 52.38M | 75.47M |
Book Value Per Share | 0.52 | 9.23 | 0.92 | 1.45 | 1.38 | 2.99 |
Common Stock | 1K | 1K | 5K | 4K | 4K | 4K |
Retained Earnings | -246.19M | -106.13M | -613.73M | -372.37M | -227.15M | -145.38M |
Comprehensive Income | n/a | n/a | n/a | n/a | -150.45M | -143.74M |
Shareholders Equity | 7.99M | 133.58M | 43.5M | 58.06M | 52.38M | 75.47M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove INBX